Login to Your Account



Bench Press: BioWorld looks at translational medicine


Monday, February 24, 2014
A team from the Swedish Karolinska Institutet has developed a strategy to preferentially target nondividing cells in nutrient-poor tumor regions by attacking their mitochondrial function. Classical chemotherapies target rapidly dividing cells, but not all tumor cells are dividing rapidly at any given time.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription